| Rights | Preview | Issue Date | Title | Author(s) | Type |
| openAccess | | 28-Jan-2016 | Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia | Zarrabeitia, Roberto; Ojeda-Fernández, María Luisa  ; Recio-Poveda, Lucía ; Bernabéu, Carmelo ; Parra, José A.; Albiñana, Virginia ; Botella, Luisa María | artículo |
| openAccess |  | 2020 | CLN5 in heterozygosis may protect against the development of tumors in a VHL patient | Rojas-P, Isabel de; Albiñana, Virginia ; Recio-Poveda, Lucía ; Rodriguez-Rufián, Amanda; Cuesta, Ángel M. ; Botella, Luisa María | |
| openAccess |  | 25-Nov-2013 | Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1 | Fontalba, Ana; Fernández-Luna, Jose L.; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Albiñana, Virginia ; Ojeda-Fernández, María Luisa ; Bernabéu, Carmelo ; Alcaraz, Luis A.; Botella, Luisa María | artículo |
| openAccess |  | 28-May-2019 | Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial | González-Rodríguez, Beatriz; Villar Gómez de las Heras, Karina; Aguirre, Daniel T.; Rodriguez-Padial, Luis; Albiñana, Virginia ; Recio-Poveda, Lucía ; Cuesta, Ángel M. ; Botella, Luisa María ; Jiménez Escribano, Rosa María | artículo |
| closedAccess |  | 1-May-2011 | Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells | Albiñana, Virginia ; Sanz-Rodriguez, Francisco; Recio-Poveda, Lucía ; Bernabéu, Carmelo ; Botella, Luisa María | artículo |
| openAccess |  | 24-Mar-2016 | Mice lacking endoglin in macrophages show an impaired immune response | Ojeda-Fernández, María Luisa ; Recio-Poveda, Lucía ; Aristorena, Mikel; Lastres, Pedro ; Blanco, Francisco J. ; Gallardo-Vara, Eunate ; Casas-Engel, Mateo de las ; Corbí, Angel L. ; Bernabéu, Carmelo ; Botella, Luisa María | artículo |
| openAccess |  | 26-Jun-2013 | MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells | Tabruyn, Sebastien P.; Hansen, Sylvain; Ojeda-Fernández, María Luisa ; Bovy, Nicolas; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Bernabéu, Carmelo ; Martial, Joseph A.; Botella, Luisa María ; Struman, Ingrid | artículo |
| openAccess |  | 23-Feb-2017 | Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1 | Albiñana, Virginia ; Zafra, M. Paz; Colau, Jorge; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Olavarrieta, Leticia; Pérez-Pérez, Julián; Botella, Luisa María | artículo |
| openAccess | | 3-May-2012 | Propranolol as an antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia | Albiñana, Virginia ; Recio-Poveda, Lucía ; Zarrabeitia, Roberto; Bernabéu, Carmelo ; Botella, Luisa María | artículo |
| closedAccess | | Apr-2010 | Reduced plasma levels of Ang-2 and sEng as novel biomarkers in Hereditary Hemorrhagic Telangiectasia (HHT) | Ojeda-Fernández, María Luisa ; Barrios, Laura ; Rodríguez-Barbero, Alicia; Recio-Poveda, Lucía ; Bernabéu, Carmelo ; Botella, Luisa María | artículo |
|  | 29-Jun-2017 | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease | Albiñana, Virginia ; Jiménez Escribano, Rosa María; Soler, Isabel; Rodríguez Padial, Luis; Recio-Poveda, Lucía ; Villar Gómez de las Heras, Karina; Botella, Luisa María | artículo |
| openAccess |  | 31-Mar-2015 | Research on potential biomarkers in hereditary hemorrhagic telangiectasia | Botella, Luisa María ; Albiñana, Virginia ; Ojeda-Fernández, María Luisa ; Recio-Poveda, Lucía ; Bernabéu, Carmelo | artículo |
| openAccess |  | 2020 | Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding | Albiñana, Virginia ; Cuesta, Ángel M. ; Rojas-P, Isabel de; Gallardo-Vara; Recio-Poveda, Lucía ; Bernabéu, Carmelo ; Botella, Luisa María | artículo |
| openAccess |  | 27-Apr-2021 | SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population | Marcos, Sol; Albiñana, Virginia ; Recio-Poveda, Lucía ; Tarazona, Belisa; Verde-González, María Patrocinio; Ojeda-Fernández, María Luisa ; Botella, Luisa María | artículo |
| openAccess |  | 25-Aug-2020 | Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel–Lindau disease | Albiñana, Virginia ; Gallardo-Vara, Eunate ; Rojas-P, Isabel de; Recio-Poveda, Lucía ; Aguado, Tania; Canto-Cano, Ana; Aguirre, Daniel T.; Serra, Marcelo M.; González-Peramato, Pilar; Martínez-Piñeiro, Luis; Cuesta, Ángel M. ; Botella, Luisa María | artículo |
| openAccess |  | 11-Jul-2019 | The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease | Cuesta, Ángel M. ; Albiñana, Virginia ; Gallardo-Vara, Eunate ; Recio-Poveda, Lucía ; I. de Rojas-P; Villar Gómez de las Heras, Karina; Aguirre, Daniel T.; Botella, Luisa María | artículo |
| openAccess |  | 2019 | Topically applied etamsylate: a new orphan drugfor HHT-derived epistaxis (antiangiogenesisthrough FGF pathway inhibition) | Albiñana, Virginia ; Giménez-Gallego, Guillermo ; García-Mato, Ángela; Palacios, Patricia; Recio-Poveda, Lucía ; Cuesta, Ángel M. ; Patier, José-Luis; Botella, Luisa María | artículo |
